Jacobson Pharma Corporation Limited (2633.HK)

HKD 1.01

(0.0%)

Revenue Summary of Jacobson Pharma Corporation Limited

  • Jacobson Pharma Corporation Limited's latest annual revenue in 2023 was 1.46 Billion HKD , down -17.8% from previous year.
  • Jacobson Pharma Corporation Limited's latest quarterly revenue in 2023 FY was 1.46 Billion HKD , down -17.8% from previous quarter.
  • Jacobson Pharma Corporation Limited reported a annual revenue of 1.78 Billion HKD in annual revenue 2022, up 11.91% from previous year.
  • Jacobson Pharma Corporation Limited reported a annual revenue of 1.59 Billion HKD in annual revenue 2021, up 10.35% from previous year.
  • Jacobson Pharma Corporation Limited reported a quarterly revenue of 752.88 Million HKD for 2023 Q4, down 0.0% from previous quarter.
  • Jacobson Pharma Corporation Limited reported a quarterly revenue of 714.91 Million HKD for 2023 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of Jacobson Pharma Corporation Limited (2023 - 2013)

Historical Annual Revenue of Jacobson Pharma Corporation Limited (2023 - 2013)

Year Revenue Revenue Growth
2023 1.46 Billion HKD -17.8%
2022 1.78 Billion HKD 11.91%
2021 1.59 Billion HKD 10.35%
2020 1.44 Billion HKD -7.99%
2019 1.57 Billion HKD 6.31%
2018 1.47 Billion HKD -4.56%
2017 1.54 Billion HKD 23.31%
2016 1.25 Billion HKD 15.88%
2015 1.08 Billion HKD 14.38%
2014 947.59 Million HKD 2.31%
2013 926.18 Million HKD 0.0%

Peer Revenue Comparison of Jacobson Pharma Corporation Limited

Name Revenue Revenue Difference
Pak Fah Yeow International Limited 259.15 Million HKD -466.372%
Grand Pharmaceutical Group Limited 10.52 Billion HKD 86.06%
Extrawell Pharmaceutical Holdings Limited 59.09 Million HKD -2383.668%
Wai Yuen Tong Medicine Holdings Limited 783.88 Million HKD -87.248%
Qianhai Health Holdings Limited 961.29 Million HKD -52.69%
Lee's Pharmaceutical Holdings Limited 1.05 Billion HKD -39.388%
Essex Bio-Technology Limited 1.7 Billion HKD 13.991%
Tongfang Kontafarma Holdings Limited 809.1 Million HKD -81.41%
PuraPharm Corporation Limited 406.85 Million HKD -260.763%
SSY Group Limited 6.46 Billion HKD 77.289%
JBM (Healthcare) Limited 648.41 Million HKD -126.367%
China Resources Pharmaceutical Group Limited 270.39 Billion HKD 99.457%